What this evidence supports
In a 2025 discussion-only request for public comment, FDA asked about post-deployment AI-device performance and drift, evaluation infrastructure, clinical outcomes and user feedback, and human-AI interaction.
What it does not establish
The request's comment period ended December 1, 2025. It is discussion-only—not draft or final guidance, an adopted framework, an enforceable requirement, or a policy change.
Answer-ready summary
FDA's September 2025 discussion-only request asked about lifecycle monitoring for AI-enabled medical-device performance; comments closed December 1, 2025, and the request is not guidance or policy.
Record details
- Decision priority
- Historical
- Current status
- Closed request for public comment · discussion only · not draft/final guidance or policy
- Evidence tracks
- Technologies/care models · Human outcomes
- Source authority
- Primary/authoritative
- Source organization
- FDA
- Evidence design
- Federal policy/science discussion
- Applicability
- Applicable to decisions about the stated program, policy, standard, or development context; not evidence of clinical benefit beyond the cited scope.
- Confidence for the stated claim
- High
- Freshness
- Historical
- Record date
- 2025-09-30
- Source updated
- 2025-09-30
- Last verified
- 2026-09-03
- Review due
- On material source change; preserve as a dated record.
- Version
- 1.1
- Revision state
- Version 1.1 corrects the record date from August 8, 2026 to the source publication date of September 30, 2025, recasts the item as a closed discussion-only request, and records the September 3, 2026 re-verification.
Evidence record fields
- Claim supported
- In a 2025 discussion-only request for public comment, FDA asked about post-deployment AI-device performance and drift, evaluation infrastructure, clinical outcomes and user feedback, and human-AI interaction.
- Source type and design
- Federal policy/science discussion
- Population and setting
- Not a participant-level clinical-study population in this source type. The program, policy, regulatory, standards, or research context described by the cited source.
- Intervention/exposure and comparator
- Not evaluated as a comparative intervention or exposure in the cited administrative or program source. No comparator is reported for this source-bounded claim.
- Outcome or endpoint
- The program, policy, regulatory, standards, or development state stated in the claim supported; no clinical outcome is inferred.
- Follow-up duration
- No clinical follow-up duration is reported for this source-bounded claim.
- Effect estimate and uncertainty
- No clinical effect estimate is reported. No statistical uncertainty estimate is reported; uncertainty is bounded through the source scope and stated limitations.
- Harms/adverse events
- No harms or adverse-event analysis is reported for this source-bounded administrative or program claim.
- Missing data and attrition
- Not reported; this record does not analyze participant-level data. Not applicable or not reported; no longitudinal participant cohort is analyzed.
- Bias/limitations
- The request's comment period ended December 1, 2025. It is discussion-only—not draft or final guidance, an adopted framework, an enforceable requirement, or a policy change.
- Applicability/generalizability
- Applicable to decisions about the stated program, policy, standard, or development context; not evidence of clinical benefit beyond the cited scope.
- Funding/conflicts
- Funding or sponsorship is recorded only where the cited source and claim state it; otherwise it is not assessed in this record. No conflict-of-interest assessment is reported for this administrative or program-source record.
- Replication or corroboration
- The administrative or program claim is anchored to the cited authoritative source; independent clinical replication is not implied.
- Decision use
- Use as source-bounded context for Clinicians, Innovators, Health-system leaders, Policymakers, Public/patients; do not use as stand-alone evidence of safety, efficacy, coverage, endorsement, or scaled adoption.
- Last reviewed / review due
- Last reviewed 2026-09-03; review due On material source change; preserve as a dated record.
For this decision
Clinicians · Innovators · Health-system leaders · Policymakers · Public/patients